Purpose of the development: Purpose. Technology leads to new drugs for Ukraine antigemofilicheskie - coagulation factors VIII and IX, both directly from the plasma, and with "cryoprecipitate", which is now the main domestic antigemofilicheskim means.

Recommended application field: Pharmaceutical companies.

Advantages over analogues: The advantage of the proposed technology is the simultaneous neutralization of pathogenic viruses that can be adsorbed on proteins in human blood, and transmitted them to injections. Only the use of chromatographic methods for the isolation and purification of proteins allows the use of certain salts and detergents for virus inactivation and subsequent removal of these ingredients. The technology also allows the cleaning process to remove possible prion proteins.

The development stage readiness: Ready for application

corresponds technical description
Ready for implementation

Possibility of transfer abroad:
Licence's sale
Licence's sale
Realization of finished commodity

Photo

Country Ukraine

For additional information turn to:
E-mail: gal@uintei.kiev.ua